Merck & Co., Inc. (MRK) Total liabilities 2016–2025
Merck & Co., Inc. (MRK) total liabilities at each fiscal year-end, per SEC filings.
$84.3BFY2025 · since FY2016: $55.3B → $84.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $84.3B | +19.0% |
| FY2024 | $70.8B | +2.5% |
| FY2023 | $69.1B | +9.4% |
| FY2022 | $63.2B | -6.4% |
| FY2021 | $67.5B | +1.9% |
| FY2020 | $66.3B | +13.3% |
| FY2019 | $58.5B | +4.6% |
| FY2018 | $55.9B | +4.5% |
| FY2017 | $53.5B | -3.2% |
| FY2016 | $55.3B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice